Liquid biopsies in patients with multiple myeloma precursor conditions

Updated: Sep 28, 2018

Mark W. Bustoros, MD, a postdoctoral fellow at Dana-Farber Cancer Institute, Harvard Medical School, discusses ongoing research exploring the use of liquid biopsies in patients with smoldering multiple myeloma in this Targeted Oncology +watch video

Mark Bustoros, MD

.

Dana-Farber Cancer Institute logo
Center for Prevention of Progression of Blood Cancers

© 2018 Dana-Farber Cancer Institute |  Terms of Use  |   Privacy Policy